148 related articles for article (PubMed ID: 38362762)
1. Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysis.
Park JH; Shin JI; Lim BJ
Histopathology; 2024 Jun; 84(7):1079-1091. PubMed ID: 38362762
[TBL] [Abstract][Full Text] [Related]
2. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of tumour budding in squamous cell carcinoma of the lung: a systematic review and meta-analysis.
Wankhede D; Hofman P; Grover S
Histopathology; 2023 Mar; 82(4):521-530. PubMed ID: 36217904
[TBL] [Abstract][Full Text] [Related]
4. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor budding in biliary tract cancer.
Regmi P; Paudyal A; Paudyal P; Hu HJ; Liu F; Ma WJ; Jin YW; Li FY
Eur J Surg Oncol; 2022 Jan; 48(1):160-168. PubMed ID: 34412954
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding in oral squamous cell carcinoma: a meta-analysis.
Almangush A; Pirinen M; Heikkinen I; Mäkitie AA; Salo T; Leivo I
Br J Cancer; 2018 Feb; 118(4):577-586. PubMed ID: 29190636
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and prognostic role of chemokine receptor CXCR4 expression in pancreatic ductal adenocarcinoma, a meta-analysis and literature review.
Ding Y; Du Y
Int J Surg; 2019 May; 65():32-38. PubMed ID: 30902754
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.
Zhang Y; Li Z; Huang Y; Zou B; Xu Y
BMJ Open; 2024 Jan; 14(1):e073887. PubMed ID: 38296306
[TBL] [Abstract][Full Text] [Related]
11. Tumour budding and its clinical implications in gastrointestinal cancers.
Zlobec I; Berger MD; Lugli A
Br J Cancer; 2020 Sep; 123(5):700-708. PubMed ID: 32601463
[TBL] [Abstract][Full Text] [Related]
12. Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma.
Petrova E; Zielinski V; Bolm L; Schreiber C; Knief J; Thorns C; Bronsert P; Timme-Bronsert S; Bausch D; Perner S; Keck T; Wellner U
Virchows Arch; 2020 Apr; 476(4):561-568. PubMed ID: 31786688
[TBL] [Abstract][Full Text] [Related]
13. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
[TBL] [Abstract][Full Text] [Related]
14. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.
O'Connor K; Li-Chang HH; Kalloger SE; Peixoto RD; Webber DL; Owen DA; Driman DK; Kirsch R; Serra S; Scudamore CH; Renouf DJ; Schaeffer DF
Am J Surg Pathol; 2015 Apr; 39(4):472-8. PubMed ID: 25634751
[TBL] [Abstract][Full Text] [Related]
15. Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma.
Lohneis P; Sinn M; Klein F; Bischoff S; Striefler JK; Wislocka L; Sinn BV; Pelzer U; Oettle H; Riess H; Denkert C; Bläker H; Jühling A
Br J Cancer; 2018 May; 118(11):1485-1491. PubMed ID: 29755112
[TBL] [Abstract][Full Text] [Related]
16. Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.
Petrelli F; Pezzica E; Cabiddu M; Coinu A; Borgonovo K; Ghilardi M; Lonati V; Corti D; Barni S
J Gastrointest Cancer; 2015 Sep; 46(3):212-8. PubMed ID: 25994502
[TBL] [Abstract][Full Text] [Related]
17. Tumor budding in breast carcinoma: A systematic review and meta-analysis.
Buch A; Khan U; Rathod H; Jain K; Dwivedi A; Rajesh A
J Cancer Res Ther; 2023 Oct; 19(7):1697-1713. PubMed ID: 38376268
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis.
Guo YX; Zhang ZZ; Zhao G; Zhao EH
World J Gastrointest Oncol; 2019 Oct; 11(10):898-908. PubMed ID: 31662828
[TBL] [Abstract][Full Text] [Related]
19. Is tumor necrosis a clinical prognostic factor in hepato-biliary-pancreatic cancers? A systematic review and meta-analysis.
Yang S; Hu H; Hu Y; Dai Y; Zou R; Lv T; Li F
Cancer Med; 2023 May; 12(10):11166-11176. PubMed ID: 36951535
[TBL] [Abstract][Full Text] [Related]
20. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
